Hepatitis C Virus Genotyping/Viral Load/Drug Resistance Test
Blood Sample
Free Home Collection
Digital Smart Report
Recommended for Male/Female
NABL & CAP Certified Labs
Trusted by Leading Doctors & Organizations
About Hepatitis C Genotyping test
Hepatitis C is caused by the hepatitis C virus and is spread through contaminated blood. It causes inflammation of the liver, sometimes leading to severe liver damage.
Hepatitis C virus genotyping and viral load drug resistance testing determines resistance to HCV directly acting agents (DAA) in certain HCV genotypes. This test helps in optimizing the DAA treatment on an individual patient basis.
Causes of HCV infection:
HCV is a bloodborne virus. It is most commonly transmitted through,
- Re-use of syringes and needles
- Sharing of injecting needles
- Transfusion of unscreened blood and blood products
Symptoms of HCV infection:
In the initial infection period, most people do not exhibit any symptoms. A few typical symptoms include:
Who should get tested for HCV genotyping and viral load drug resistance?
This test is recommended for people:
Test preparation
No special preparation is required for HCV genotyping and viral load drug resistance.
Interpretation of the Test Results
Positive test results
A positive hepatitis C genotyping and viral load drug resistance test result indicates that the hepatitis C virus is multiplying inside the body with no positive treatment effect on an individual.
Negative test results
A negative test result indicates that there is no sign of Hepatitis C infection in an individual’s body.
FAQs on Hepatitis C Genotyping test
It will take about 7–10 working days to get the test results of Hepatitis C genotyping and viral load drug resistance
Limitations include rejection of serum or plasma samples contaminated by microbes and the possibility of errors due to improper sample collection
There are no risks associated with the Hepatitis C genotyping test. However, mild pain at the sample withdrawal site may occur and usually subsides within a few minutes to hours
To reduce the risk of hepatitis C infection, avoid sharing injections, do not share personal items like razors or toothbrushes that may contact blood, and exercise caution as there is no vaccine available for hepatitis C
Yes, HIV-positive individuals should be screened for hepatitis B and C, as hepatitis infections are commonly seen in people living with HIV
Fever
Fatigue
Decreased appetite
Nausea
Vomiting
Abdominal pain
Dark urine
Pale faeces
Joint pain
Jaundice (yellowing of skin and eye white)
Who have been diagnosed with HCV infection
Who have been diagnosed with and treated for HCV infection
Who have been treated for HCV infection and developed resistance to the therapy
Routine monitoring of HCV infected persons
